Document is current
Any future updates will be listed below
-
Authors
de Jonge, Jeroen C. http://orcid.org/0000-0002-0025-8760
Woodhouse, Lisa J.
Reinink, Hendrik
van der Worp, H. Bart
Bath, Philip M.
,
-
Funding
Funding for this research was provided by:
Horizon 2020 (634809)
- License Information
-
More Information
Article History
Received: 12 May 2020
Accepted: 31 August 2020
First Online: 26 October 2020
Ethics approval and consent to participate
: The primary ethics approval for the PRECIOUS trial has been provided by the Medical Ethics Committee of the University Medical Center Utrecht, Utrecht, the Netherlands (NL54304.041.13). We have obtained informed consent from all participants in the study.
: Not applicable.
: HBvdW served as a consultant to Boehringer Ingelheim, Bayer, and LivaNova. PMB has served on advisory boards with DiaMedica, Moleac, Nestle, Phagenesis, Platelet Solutions, and Sanofi.
